Global Innovative Small Molecule Targeted Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Innovative Small Molecule Targeted Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Innovative Small Molecule Targeted Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Innovative Small Molecule Targeted Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Innovative Small Molecule Targeted Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Innovative Small Molecule Targeted Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Innovative Small Molecule Targeted Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Innovative Small Molecule Targeted Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Innovative Small Molecule Targeted Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Genetech, Novartis and Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Innovative Small Molecule Targeted Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Innovative Small Molecule Targeted Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Innovative Small Molecule Targeted Drugs, with price, sales, revenue and global market share of Innovative Small Molecule Targeted Drugs from 2018 to 2023.
Chapter 3, the Innovative Small Molecule Targeted Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Innovative Small Molecule Targeted Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Innovative Small Molecule Targeted Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Innovative Small Molecule Targeted Drugs.
Chapter 14 and 15, to describe Innovative Small Molecule Targeted Drugs sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Innovative Small Molecule Targeted Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Innovative Small Molecule Targeted Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Innovative Small Molecule Targeted Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Innovative Small Molecule Targeted Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Innovative Small Molecule Targeted Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Innovative Small Molecule Targeted Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Innovative Small Molecule Targeted Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Pfizer, Genetech, Novartis and Bayer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Innovative Small Molecule Targeted Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Kinase Inhibitors
- Epigenetic Inhibitors
- Proteasome Inhibitor
- Hospital
- Pharmacy
- Roche
- Pfizer
- Genetech
- Novartis
- Bayer
- Abbive
- Jiangsu Hengrui Pharmaceuticals
- Jiangsu Chia Tai-Tianqing Pharmaceutical
- QILU Pharmaceutical
- Betta Pharmaceuticals
- Shanghai Junshi Biosciences
- Shanghai Allist Pharmaceuticals
- Shenzhen Chipscreen Biosciences
- Innovent Biologics, Inc.
- Hinova Pharmaceuticals
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Innovative Small Molecule Targeted Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Innovative Small Molecule Targeted Drugs, with price, sales, revenue and global market share of Innovative Small Molecule Targeted Drugs from 2018 to 2023.
Chapter 3, the Innovative Small Molecule Targeted Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Innovative Small Molecule Targeted Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Innovative Small Molecule Targeted Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Innovative Small Molecule Targeted Drugs.
Chapter 14 and 15, to describe Innovative Small Molecule Targeted Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Innovative Small Molecule Targeted Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Innovative Small Molecule Targeted Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Kinase Inhibitors
1.3.3 Epigenetic Inhibitors
1.3.4 Proteasome Inhibitor
1.4 Market Analysis by Application
1.4.1 Overview: Global Innovative Small Molecule Targeted Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Innovative Small Molecule Targeted Drugs Market Size & Forecast
1.5.1 Global Innovative Small Molecule Targeted Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Innovative Small Molecule Targeted Drugs Sales Quantity (2018-2029)
1.5.3 Global Innovative Small Molecule Targeted Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Innovative Small Molecule Targeted Drugs Product and Services
2.1.4 Roche Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Innovative Small Molecule Targeted Drugs Product and Services
2.2.4 Pfizer Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Genetech
2.3.1 Genetech Details
2.3.2 Genetech Major Business
2.3.3 Genetech Innovative Small Molecule Targeted Drugs Product and Services
2.3.4 Genetech Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genetech Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Innovative Small Molecule Targeted Drugs Product and Services
2.4.4 Novartis Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Innovative Small Molecule Targeted Drugs Product and Services
2.5.4 Bayer Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Recent Developments/Updates
2.6 Abbive
2.6.1 Abbive Details
2.6.2 Abbive Major Business
2.6.3 Abbive Innovative Small Molecule Targeted Drugs Product and Services
2.6.4 Abbive Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abbive Recent Developments/Updates
2.7 Jiangsu Hengrui Pharmaceuticals
2.7.1 Jiangsu Hengrui Pharmaceuticals Details
2.7.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.7.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.7.4 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
2.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
2.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
2.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
2.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
2.9 QILU Pharmaceutical
2.9.1 QILU Pharmaceutical Details
2.9.2 QILU Pharmaceutical Major Business
2.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
2.9.4 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 QILU Pharmaceutical Recent Developments/Updates
2.10 Betta Pharmaceuticals
2.10.1 Betta Pharmaceuticals Details
2.10.2 Betta Pharmaceuticals Major Business
2.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.10.4 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Betta Pharmaceuticals Recent Developments/Updates
2.11 Shanghai Junshi Biosciences
2.11.1 Shanghai Junshi Biosciences Details
2.11.2 Shanghai Junshi Biosciences Major Business
2.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product and Services
2.11.4 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Junshi Biosciences Recent Developments/Updates
2.12 Shanghai Allist Pharmaceuticals
2.12.1 Shanghai Allist Pharmaceuticals Details
2.12.2 Shanghai Allist Pharmaceuticals Major Business
2.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.12.4 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.13 Shenzhen Chipscreen Biosciences
2.13.1 Shenzhen Chipscreen Biosciences Details
2.13.2 Shenzhen Chipscreen Biosciences Major Business
2.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product and Services
2.13.4 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shenzhen Chipscreen Biosciences Recent Developments/Updates
2.14 Innovent Biologics, Inc.
2.14.1 Innovent Biologics, Inc. Details
2.14.2 Innovent Biologics, Inc. Major Business
2.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product and Services
2.14.4 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Innovent Biologics, Inc. Recent Developments/Updates
2.15 Hinova Pharmaceuticals
2.15.1 Hinova Pharmaceuticals Details
2.15.2 Hinova Pharmaceuticals Major Business
2.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.15.4 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hinova Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INNOVATIVE SMALL MOLECULE TARGETED DRUGS BY MANUFACTURER
3.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Innovative Small Molecule Targeted Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Innovative Small Molecule Targeted Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Innovative Small Molecule Targeted Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Innovative Small Molecule Targeted Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Innovative Small Molecule Targeted Drugs Manufacturer Market Share in 2022
3.5 Innovative Small Molecule Targeted Drugs Market: Overall Company Footprint Analysis
3.5.1 Innovative Small Molecule Targeted Drugs Market: Region Footprint
3.5.2 Innovative Small Molecule Targeted Drugs Market: Company Product Type Footprint
3.5.3 Innovative Small Molecule Targeted Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Innovative Small Molecule Targeted Drugs Market Size by Region
4.1.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Innovative Small Molecule Targeted Drugs Average Price by Region (2018-2029)
4.2 North America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.3 Europe Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.5 South America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
5.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Type (2018-2029)
5.3 Global Innovative Small Molecule Targeted Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
6.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Application (2018-2029)
6.3 Global Innovative Small Molecule Targeted Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
7.2 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
7.3 North America Innovative Small Molecule Targeted Drugs Market Size by Country
7.3.1 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Innovative Small Molecule Targeted Drugs Market Size by Country
8.3.1 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Innovative Small Molecule Targeted Drugs Market Size by Region
9.3.1 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
10.2 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
10.3 South America Innovative Small Molecule Targeted Drugs Market Size by Country
10.3.1 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Innovative Small Molecule Targeted Drugs Market Size by Country
11.3.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Innovative Small Molecule Targeted Drugs Market Drivers
12.2 Innovative Small Molecule Targeted Drugs Market Restraints
12.3 Innovative Small Molecule Targeted Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Innovative Small Molecule Targeted Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Innovative Small Molecule Targeted Drugs
13.3 Innovative Small Molecule Targeted Drugs Production Process
13.4 Innovative Small Molecule Targeted Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Innovative Small Molecule Targeted Drugs Typical Distributors
14.3 Innovative Small Molecule Targeted Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Innovative Small Molecule Targeted Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Innovative Small Molecule Targeted Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Kinase Inhibitors
1.3.3 Epigenetic Inhibitors
1.3.4 Proteasome Inhibitor
1.4 Market Analysis by Application
1.4.1 Overview: Global Innovative Small Molecule Targeted Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.5 Global Innovative Small Molecule Targeted Drugs Market Size & Forecast
1.5.1 Global Innovative Small Molecule Targeted Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Innovative Small Molecule Targeted Drugs Sales Quantity (2018-2029)
1.5.3 Global Innovative Small Molecule Targeted Drugs Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Innovative Small Molecule Targeted Drugs Product and Services
2.1.4 Roche Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Innovative Small Molecule Targeted Drugs Product and Services
2.2.4 Pfizer Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Pfizer Recent Developments/Updates
2.3 Genetech
2.3.1 Genetech Details
2.3.2 Genetech Major Business
2.3.3 Genetech Innovative Small Molecule Targeted Drugs Product and Services
2.3.4 Genetech Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genetech Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Innovative Small Molecule Targeted Drugs Product and Services
2.4.4 Novartis Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Innovative Small Molecule Targeted Drugs Product and Services
2.5.4 Bayer Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer Recent Developments/Updates
2.6 Abbive
2.6.1 Abbive Details
2.6.2 Abbive Major Business
2.6.3 Abbive Innovative Small Molecule Targeted Drugs Product and Services
2.6.4 Abbive Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Abbive Recent Developments/Updates
2.7 Jiangsu Hengrui Pharmaceuticals
2.7.1 Jiangsu Hengrui Pharmaceuticals Details
2.7.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.7.3 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.7.4 Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.8 Jiangsu Chia Tai-Tianqing Pharmaceutical
2.8.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Details
2.8.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
2.8.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
2.8.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
2.9 QILU Pharmaceutical
2.9.1 QILU Pharmaceutical Details
2.9.2 QILU Pharmaceutical Major Business
2.9.3 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
2.9.4 QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 QILU Pharmaceutical Recent Developments/Updates
2.10 Betta Pharmaceuticals
2.10.1 Betta Pharmaceuticals Details
2.10.2 Betta Pharmaceuticals Major Business
2.10.3 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.10.4 Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Betta Pharmaceuticals Recent Developments/Updates
2.11 Shanghai Junshi Biosciences
2.11.1 Shanghai Junshi Biosciences Details
2.11.2 Shanghai Junshi Biosciences Major Business
2.11.3 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product and Services
2.11.4 Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Junshi Biosciences Recent Developments/Updates
2.12 Shanghai Allist Pharmaceuticals
2.12.1 Shanghai Allist Pharmaceuticals Details
2.12.2 Shanghai Allist Pharmaceuticals Major Business
2.12.3 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.12.4 Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
2.13 Shenzhen Chipscreen Biosciences
2.13.1 Shenzhen Chipscreen Biosciences Details
2.13.2 Shenzhen Chipscreen Biosciences Major Business
2.13.3 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product and Services
2.13.4 Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shenzhen Chipscreen Biosciences Recent Developments/Updates
2.14 Innovent Biologics, Inc.
2.14.1 Innovent Biologics, Inc. Details
2.14.2 Innovent Biologics, Inc. Major Business
2.14.3 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product and Services
2.14.4 Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Innovent Biologics, Inc. Recent Developments/Updates
2.15 Hinova Pharmaceuticals
2.15.1 Hinova Pharmaceuticals Details
2.15.2 Hinova Pharmaceuticals Major Business
2.15.3 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
2.15.4 Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Hinova Pharmaceuticals Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INNOVATIVE SMALL MOLECULE TARGETED DRUGS BY MANUFACTURER
3.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Innovative Small Molecule Targeted Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Innovative Small Molecule Targeted Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Innovative Small Molecule Targeted Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Innovative Small Molecule Targeted Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Innovative Small Molecule Targeted Drugs Manufacturer Market Share in 2022
3.5 Innovative Small Molecule Targeted Drugs Market: Overall Company Footprint Analysis
3.5.1 Innovative Small Molecule Targeted Drugs Market: Region Footprint
3.5.2 Innovative Small Molecule Targeted Drugs Market: Company Product Type Footprint
3.5.3 Innovative Small Molecule Targeted Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Innovative Small Molecule Targeted Drugs Market Size by Region
4.1.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Innovative Small Molecule Targeted Drugs Average Price by Region (2018-2029)
4.2 North America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.3 Europe Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.5 South America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
5.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Type (2018-2029)
5.3 Global Innovative Small Molecule Targeted Drugs Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
6.2 Global Innovative Small Molecule Targeted Drugs Consumption Value by Application (2018-2029)
6.3 Global Innovative Small Molecule Targeted Drugs Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
7.2 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
7.3 North America Innovative Small Molecule Targeted Drugs Market Size by Country
7.3.1 North America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Innovative Small Molecule Targeted Drugs Market Size by Country
8.3.1 Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Innovative Small Molecule Targeted Drugs Market Size by Region
9.3.1 Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
10.2 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
10.3 South America Innovative Small Molecule Targeted Drugs Market Size by Country
10.3.1 South America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Innovative Small Molecule Targeted Drugs Market Size by Country
11.3.1 Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Innovative Small Molecule Targeted Drugs Market Drivers
12.2 Innovative Small Molecule Targeted Drugs Market Restraints
12.3 Innovative Small Molecule Targeted Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Innovative Small Molecule Targeted Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Innovative Small Molecule Targeted Drugs
13.3 Innovative Small Molecule Targeted Drugs Production Process
13.4 Innovative Small Molecule Targeted Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Innovative Small Molecule Targeted Drugs Typical Distributors
14.3 Innovative Small Molecule Targeted Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Innovative Small Molecule Targeted Drugs Product and Services
Table 6. Roche Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Innovative Small Molecule Targeted Drugs Product and Services
Table 11. Pfizer Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Genetech Basic Information, Manufacturing Base and Competitors
Table 14. Genetech Major Business
Table 15. Genetech Innovative Small Molecule Targeted Drugs Product and Services
Table 16. Genetech Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genetech Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Innovative Small Molecule Targeted Drugs Product and Services
Table 21. Novartis Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. Bayer Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Major Business
Table 25. Bayer Innovative Small Molecule Targeted Drugs Product and Services
Table 26. Bayer Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bayer Recent Developments/Updates
Table 28. Abbive Basic Information, Manufacturing Base and Competitors
Table 29. Abbive Major Business
Table 30. Abbive Innovative Small Molecule Targeted Drugs Product and Services
Table 31. Abbive Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abbive Recent Developments/Updates
Table 33. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Hengrui Pharmaceuticals Major Business
Table 35. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 36. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 38. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
Table 40. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
Table 41. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 43. QILU Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. QILU Pharmaceutical Major Business
Table 45. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
Table 46. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. QILU Pharmaceutical Recent Developments/Updates
Table 48. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Betta Pharmaceuticals Major Business
Table 50. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 51. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Betta Pharmaceuticals Recent Developments/Updates
Table 53. Shanghai Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Junshi Biosciences Major Business
Table 55. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product and Services
Table 56. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Junshi Biosciences Recent Developments/Updates
Table 58. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Shanghai Allist Pharmaceuticals Major Business
Table 60. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 61. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 63. Shenzhen Chipscreen Biosciences Basic Information, Manufacturing Base and Competitors
Table 64. Shenzhen Chipscreen Biosciences Major Business
Table 65. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product and Services
Table 66. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shenzhen Chipscreen Biosciences Recent Developments/Updates
Table 68. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Innovent Biologics, Inc. Major Business
Table 70. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product and Services
Table 71. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Innovent Biologics, Inc. Recent Developments/Updates
Table 73. Hinova Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Hinova Pharmaceuticals Major Business
Table 75. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 76. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hinova Pharmaceuticals Recent Developments/Updates
Table 78. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Innovative Small Molecule Targeted Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Innovative Small Molecule Targeted Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Innovative Small Molecule Targeted Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Innovative Small Molecule Targeted Drugs Production Site of Key Manufacturer
Table 83. Innovative Small Molecule Targeted Drugs Market: Company Product Type Footprint
Table 84. Innovative Small Molecule Targeted Drugs Market: Company Product Application Footprint
Table 85. Innovative Small Molecule Targeted Drugs New Market Entrants and Barriers to Market Entry
Table 86. Innovative Small Molecule Targeted Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Innovative Small Molecule Targeted Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Innovative Small Molecule Targeted Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Innovative Small Molecule Targeted Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Innovative Small Molecule Targeted Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Innovative Small Molecule Targeted Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Innovative Small Molecule Targeted Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Innovative Small Molecule Targeted Drugs Raw Material
Table 146. Key Manufacturers of Innovative Small Molecule Targeted Drugs Raw Materials
Table 147. Innovative Small Molecule Targeted Drugs Typical Distributors
Table 148. Innovative Small Molecule Targeted Drugs Typical Customers
List of Figures
Figure 1. Innovative Small Molecule Targeted Drugs Picture
Figure 2. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Type in 2022
Figure 4. Kinase Inhibitors Examples
Figure 5. Epigenetic Inhibitors Examples
Figure 6. Proteasome Inhibitor Examples
Figure 7. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Pharmacy Examples
Figure 11. Global Innovative Small Molecule Targeted Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Innovative Small Molecule Targeted Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Innovative Small Molecule Targeted Drugs Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Innovative Small Molecule Targeted Drugs Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Innovative Small Molecule Targeted Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Innovative Small Molecule Targeted Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Innovative Small Molecule Targeted Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Innovative Small Molecule Targeted Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Innovative Small Molecule Targeted Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Region (2018-2029)
Figure 53. China Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Innovative Small Molecule Targeted Drugs Market Drivers
Figure 74. Innovative Small Molecule Targeted Drugs Market Restraints
Figure 75. Innovative Small Molecule Targeted Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Innovative Small Molecule Targeted Drugs in 2022
Figure 78. Manufacturing Process Analysis of Innovative Small Molecule Targeted Drugs
Figure 79. Innovative Small Molecule Targeted Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Table 1. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Basic Information, Manufacturing Base and Competitors
Table 4. Roche Major Business
Table 5. Roche Innovative Small Molecule Targeted Drugs Product and Services
Table 6. Roche Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Innovative Small Molecule Targeted Drugs Product and Services
Table 11. Pfizer Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Pfizer Recent Developments/Updates
Table 13. Genetech Basic Information, Manufacturing Base and Competitors
Table 14. Genetech Major Business
Table 15. Genetech Innovative Small Molecule Targeted Drugs Product and Services
Table 16. Genetech Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Genetech Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Innovative Small Molecule Targeted Drugs Product and Services
Table 21. Novartis Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. Bayer Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Major Business
Table 25. Bayer Innovative Small Molecule Targeted Drugs Product and Services
Table 26. Bayer Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Bayer Recent Developments/Updates
Table 28. Abbive Basic Information, Manufacturing Base and Competitors
Table 29. Abbive Major Business
Table 30. Abbive Innovative Small Molecule Targeted Drugs Product and Services
Table 31. Abbive Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Abbive Recent Developments/Updates
Table 33. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Jiangsu Hengrui Pharmaceuticals Major Business
Table 35. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 36. Jiangsu Hengrui Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 38. Jiangsu Chia Tai-Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Jiangsu Chia Tai-Tianqing Pharmaceutical Major Business
Table 40. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
Table 41. Jiangsu Chia Tai-Tianqing Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates
Table 43. QILU Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. QILU Pharmaceutical Major Business
Table 45. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Product and Services
Table 46. QILU Pharmaceutical Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. QILU Pharmaceutical Recent Developments/Updates
Table 48. Betta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 49. Betta Pharmaceuticals Major Business
Table 50. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 51. Betta Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Betta Pharmaceuticals Recent Developments/Updates
Table 53. Shanghai Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Junshi Biosciences Major Business
Table 55. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Product and Services
Table 56. Shanghai Junshi Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Junshi Biosciences Recent Developments/Updates
Table 58. Shanghai Allist Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 59. Shanghai Allist Pharmaceuticals Major Business
Table 60. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 61. Shanghai Allist Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Shanghai Allist Pharmaceuticals Recent Developments/Updates
Table 63. Shenzhen Chipscreen Biosciences Basic Information, Manufacturing Base and Competitors
Table 64. Shenzhen Chipscreen Biosciences Major Business
Table 65. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Product and Services
Table 66. Shenzhen Chipscreen Biosciences Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shenzhen Chipscreen Biosciences Recent Developments/Updates
Table 68. Innovent Biologics, Inc. Basic Information, Manufacturing Base and Competitors
Table 69. Innovent Biologics, Inc. Major Business
Table 70. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Product and Services
Table 71. Innovent Biologics, Inc. Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Innovent Biologics, Inc. Recent Developments/Updates
Table 73. Hinova Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Hinova Pharmaceuticals Major Business
Table 75. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Product and Services
Table 76. Hinova Pharmaceuticals Innovative Small Molecule Targeted Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Hinova Pharmaceuticals Recent Developments/Updates
Table 78. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Innovative Small Molecule Targeted Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Innovative Small Molecule Targeted Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Innovative Small Molecule Targeted Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Innovative Small Molecule Targeted Drugs Production Site of Key Manufacturer
Table 83. Innovative Small Molecule Targeted Drugs Market: Company Product Type Footprint
Table 84. Innovative Small Molecule Targeted Drugs Market: Company Product Application Footprint
Table 85. Innovative Small Molecule Targeted Drugs New Market Entrants and Barriers to Market Entry
Table 86. Innovative Small Molecule Targeted Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Innovative Small Molecule Targeted Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Innovative Small Molecule Targeted Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Innovative Small Molecule Targeted Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Innovative Small Molecule Targeted Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Innovative Small Molecule Targeted Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Innovative Small Molecule Targeted Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Innovative Small Molecule Targeted Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Innovative Small Molecule Targeted Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Innovative Small Molecule Targeted Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Innovative Small Molecule Targeted Drugs Raw Material
Table 146. Key Manufacturers of Innovative Small Molecule Targeted Drugs Raw Materials
Table 147. Innovative Small Molecule Targeted Drugs Typical Distributors
Table 148. Innovative Small Molecule Targeted Drugs Typical Customers
List of Figures
Figure 1. Innovative Small Molecule Targeted Drugs Picture
Figure 2. Global Innovative Small Molecule Targeted Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Type in 2022
Figure 4. Kinase Inhibitors Examples
Figure 5. Epigenetic Inhibitors Examples
Figure 6. Proteasome Inhibitor Examples
Figure 7. Global Innovative Small Molecule Targeted Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Pharmacy Examples
Figure 11. Global Innovative Small Molecule Targeted Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Innovative Small Molecule Targeted Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Innovative Small Molecule Targeted Drugs Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Innovative Small Molecule Targeted Drugs Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Innovative Small Molecule Targeted Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Innovative Small Molecule Targeted Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Innovative Small Molecule Targeted Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Innovative Small Molecule Targeted Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Innovative Small Molecule Targeted Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Region (2018-2029)
Figure 53. China Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Innovative Small Molecule Targeted Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Innovative Small Molecule Targeted Drugs Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Innovative Small Molecule Targeted Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Innovative Small Molecule Targeted Drugs Market Drivers
Figure 74. Innovative Small Molecule Targeted Drugs Market Restraints
Figure 75. Innovative Small Molecule Targeted Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Innovative Small Molecule Targeted Drugs in 2022
Figure 78. Manufacturing Process Analysis of Innovative Small Molecule Targeted Drugs
Figure 79. Innovative Small Molecule Targeted Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
